These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 29481636

  • 1. Effects of nutritional vitamin D supplementation on markers of bone and mineral metabolism in children with chronic kidney disease.
    Lerch C, Shroff R, Wan M, Rees L, Aitkenhead H, Kaplan Bulut I, Thurn D, Karabay Bayazit A, Niemirska A, Canpolat N, Duzova A, Azukaitis K, Yilmaz E, Yalcinkaya F, Harambat J, Kiyak A, Alpay H, Habbig S, Zaloszyc A, Soylemezoglu O, Candan C, Rosales A, Melk A, Querfeld U, Leifheit-Nestler M, Sander A, Schaefer F, Haffner D, 4C study consortium, ESPN CKD-MBD working group.
    Nephrol Dial Transplant; 2018 Dec 01; 33(12):2208-2217. PubMed ID: 29481636
    [Abstract] [Full Text] [Related]

  • 2. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C, Cheng C, Wang J, Zhang L, Purrunsing Y, Yang G, Zeng M, Huang H, Ren W, Ye Y, Ma H, Xing C, Wang N.
    Clin Nephrol; 2020 Feb 01; 93(2):65-76. PubMed ID: 31793871
    [Abstract] [Full Text] [Related]

  • 3. Early renal impairment affects hormonal regulators of calcium and bone metabolism and Wnt signalling and the response to vitamin D supplementation in healthy older adults.
    Christodoulou M, Aspray TJ, Piec I, Washbourne C, Tang JCY, Fraser WD, Schoenmakers I, VDOP Trial group, Terry J Aspray, Roger M Francis, Elaine McColl, Thomas Chadwick, Ann Prentice, Inez Schoenmakers.
    J Steroid Biochem Mol Biol; 2023 May 01; 229():106267. PubMed ID: 36739953
    [Abstract] [Full Text] [Related]

  • 4. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, Spichtig D, Poster D, Wüthrich RP, Russmann S, Serra AL.
    Nephrol Dial Transplant; 2013 Feb 01; 28(2):352-9. PubMed ID: 23129826
    [Abstract] [Full Text] [Related]

  • 5. Active vitamin D is cardioprotective in experimental uraemia but not in children with CKD Stages 3-5.
    Schön A, Leifheit-Nestler M, Deppe J, Fischer DC, Bayazit AK, Obrycki L, Canpolat N, Bulut IK, Azukaitis K, Yilmaz A, Mir S, Yalcinkaya F, Soylemezoglu O, Melk A, Stangl GI, Behnisch R, Shroff R, Bacchetta J, Querfeld U, Schaefer F, Haffner D, 4C and Study Consortium and the ESPN CKD-MBD Working Group.
    Nephrol Dial Transplant; 2021 Feb 20; 36(3):442-451. PubMed ID: 33241290
    [Abstract] [Full Text] [Related]

  • 6. Alterations in regulators of the renal-bone axis, inflammation and iron status in older people with early renal impairment and the effect of vitamin D supplementation.
    Christodoulou M, Aspray TJ, Piec I, Fraser WD, Schoenmakers I, VDOP Trial group.
    Age Ageing; 2024 May 01; 53(5):. PubMed ID: 38770543
    [Abstract] [Full Text] [Related]

  • 7. Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease.
    Doyon A, Fischer DC, Bayazit AK, Canpolat N, Duzova A, Sözeri B, Bacchetta J, Balat A, Büscher A, Candan C, Cakar N, Donmez O, Dusek J, Heckel M, Klaus G, Mir S, Özcelik G, Sever L, Shroff R, Vidal E, Wühl E, Gondan M, Melk A, Querfeld U, Haffner D, Schaefer F, 4C Study Consortium.
    PLoS One; 2015 May 01; 10(2):e0113482. PubMed ID: 25659076
    [Abstract] [Full Text] [Related]

  • 8. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
    Wan M, Smith C, Shah V, Gullet A, Wells D, Rees L, Shroff R.
    Nephrol Dial Transplant; 2013 Jan 01; 28(1):153-61. PubMed ID: 23180879
    [Abstract] [Full Text] [Related]

  • 9. Assessment of tubular reabsorption of phosphate as a surrogate marker for phosphate regulation in chronic kidney disease.
    Hong YA, Lim JH, Kim MY, Kim Y, Yang KS, Chung BH, Chung S, Choi BS, Yang CW, Kim YS, Chang YS, Park CW.
    Clin Exp Nephrol; 2015 Apr 01; 19(2):208-15. PubMed ID: 24682550
    [Abstract] [Full Text] [Related]

  • 10. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
    Portale AA, Wolf MS, Messinger S, Perwad F, Jüppner H, Warady BA, Furth SL, Salusky IB.
    Clin J Am Soc Nephrol; 2016 Nov 07; 11(11):1989-1998. PubMed ID: 27561289
    [Abstract] [Full Text] [Related]

  • 11. Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD.
    Krishnasamy R, Tan SJ, Hawley CM, Johnson DW, Stanton T, Lee K, Mudge DW, Campbell S, Elder GJ, Toussaint ND, Isbel NM.
    BMC Nephrol; 2017 Sep 04; 18(1):281. PubMed ID: 28870151
    [Abstract] [Full Text] [Related]

  • 12. Bone and Mineral Metabolism in Children with Nephropathic Cystinosis Compared with other CKD Entities.
    Ewert A, Leifheit-Nestler M, Hohenfellner K, Büscher A, Kemper MJ, Oh J, Billing H, Thumfart J, Stangl G, Baur AC, Föller M, Feger M, Weber LT, Acham-Roschitz B, Arbeiter K, Tönshoff B, Zivicnjak M, Haffner D.
    J Clin Endocrinol Metab; 2020 Aug 01; 105(8):. PubMed ID: 32413117
    [Abstract] [Full Text] [Related]

  • 13. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y, Olauson H, Vavilis G, Hammar U, Herthelius M, Axelsson J, Bárány P.
    Pediatr Nephrol; 2018 Jan 01; 33(1):147-157. PubMed ID: 28795324
    [Abstract] [Full Text] [Related]

  • 14. Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients.
    Kanda E, Yoshida M, Sasaki S.
    BMC Nephrol; 2012 Sep 26; 13():122. PubMed ID: 23013306
    [Abstract] [Full Text] [Related]

  • 15. [Mineral metabolism in patients on chronic peritoneal dialysis].
    Ceballos O ML, Rojo L A, Azócar P M, Ibacache M MJ, Delucchi B A, Quiroz Z L, Irarrázabal M C, Delgado B I, Ugarte P F, Cano Sch F.
    Rev Chil Pediatr; 2014 Feb 26; 85(1):31-9. PubMed ID: 25079181
    [Abstract] [Full Text] [Related]

  • 16. Effect of vitamin D supplementation on serum sclerostin levels in chronic kidney disease.
    Yadav AK, Kumar V, Banerjee D, Gupta KL, Jha V.
    J Steroid Biochem Mol Biol; 2018 Jun 26; 180():15-18. PubMed ID: 29331722
    [Abstract] [Full Text] [Related]

  • 17. Soluble α-klotho and its relation to kidney function and fibroblast growth factor-23.
    Scholze A, Liu Y, Pedersen L, Xia S, Roth HJ, Hocher B, Rasmussen LM, Tepel M.
    J Clin Endocrinol Metab; 2014 May 26; 99(5):E855-61. PubMed ID: 24606097
    [Abstract] [Full Text] [Related]

  • 18. Changes in bone biomarkers in response to different dosing regimens of cholecalciferol supplementation in children with chronic kidney disease.
    Kamath N, Iyengar A, Reddy HV, Sharma J, Singhal J, Ekambaram S, Uthup S, Selvam S, Wan M, Rahn A, Christiane-Fischer D, Shroff R.
    Pediatr Nephrol; 2023 Jun 26; 38(6):1907-1913. PubMed ID: 36322258
    [Abstract] [Full Text] [Related]

  • 19. The role of vitamin D replacement therapy in serum FGF23 concentration in children with myelomeningocele compared with healthy children - a preliminary study.
    Bagińska J, Liszewska A, Korzeniecka-Kozerska A.
    J Pediatr Endocrinol Metab; 2019 Nov 26; 32(11):1259-1264. PubMed ID: 31465293
    [Abstract] [Full Text] [Related]

  • 20. Interactions of sclerostin with FGF23, soluble klotho and vitamin D in renal transplantation.
    Tartaglione L, Pasquali M, Rotondi S, Muci ML, Leonangeli C, Farcomeni A, Fassino V, Mazzaferro S.
    PLoS One; 2017 Nov 26; 12(5):e0178637. PubMed ID: 28558021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.